---
pmid: '23161826'
title: Mutations in SYNGAP1 cause intellectual disability, autism, and a specific
  form of epilepsy by inducing haploinsufficiency.
authors:
- Berryer MH
- Hamdan FF
- Klitten LL
- Møller RS
- Carmant L
- Schwartzentruber J
- Patry L
- Dobrzeniecka S
- Rochefort D
- Neugnot-Cerioli M
- Lacaille JC
- Niu Z
- Eng CM
- Yang Y
- Palardy S
- Belhumeur C
- Rouleau GA
- Tommerup N
- Immken L
- Beauchamp MH
- Patel GS
- Majewski J
- Tarnopolsky MA
- Scheffzek K
- Hjalgrim H
- Michaud JL
- Di Cristo G
journal: Hum Mutat
year: '2013'
full_text_available: false
doi: 10.1002/humu.22248
---

# Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.
**Authors:** Berryer MH, Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G
**Journal:** Hum Mutat (2013)
**DOI:** [10.1002/humu.22248](https://doi.org/10.1002/humu.22248)

## Abstract

1. Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12.

Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form 
of epilepsy by inducing haploinsufficiency.

Berryer MH(1), Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, 
Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng 
CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp 
MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, 
Di Cristo G.

Author information:
(1)Centre of Excellence in Neurosciences of Université de Montréal and 
Sainte-Justine Hospital Research Center, Montréal, Québec, Canada.

De novo mutations in SYNGAP1, which codes for a RAS/RAP GTP-activating protein, 
cause nonsyndromic intellectual disability (NSID). All disease-causing point 
mutations identified until now in SYNGAP1 are truncating, raising the 
possibility of an association between this type of mutations and NSID. Here, we 
report the identification of the first pathogenic missense mutations (c.1084T>C 
[p.W362R], c.1685C>T [p.P562L]) and three novel truncating mutations (c.283dupC 
[p.H95PfsX5], c.2212_2213del [p.S738X], and (c.2184del [p.N729TfsX31]) in 
SYNGAP1 in patients with NSID. A subset of these patients also showed ataxia, 
autism, and a specific form of generalized epilepsy that can be refractory to 
treatment. All of these mutations occurred de novo, except c.283dupC, which was 
inherited from a father who is a mosaic. Biolistic transfection of wild-type 
SYNGAP1 in pyramidal cells from cortical organotypic cultures significantly 
reduced activity-dependent phosphorylated extracellular signal-regulated kinase 
(pERK) levels. In contrast, constructs expressing p.W362R, p.P562L, or the 
previously described p.R579X had no significant effect on pERK levels. These 
experiments suggest that the de novo missense mutations, p.R579X, and possibly 
all the other truncating mutations in SYNGAP1 result in a loss of its function. 
Moreover, our study confirms the involvement of SYNGAP1 in autism while 
providing novel insight into the epileptic manifestations associated with its 
disruption.

© 2012 WILEY PERIODICALS, INC.

DOI: 10.1002/humu.22248
PMID: 23161826 [Indexed for MEDLINE]
